Log in

Relevant bibliographies by topics / Bowral

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Bowral'

Author: Grafiati

Published: 4 June 2021

Last updated: 21 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Bowral.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Bowral"

1

Heenan, Tom, and David Dunstan. "Hidden histories: The Bradmans of Cootamundra and Bowral." Sport in Society 18, no. 9 (June 23, 2015): 1026–44. http://dx.doi.org/10.1080/17430437.2015.1011878.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Masterman-Smith, Helen, and Drew Cottle. "‘Bradstow Revisited’: A comparative study of class politics in Bowral, 1974 and 1997." Rural Society 11, no. 1 (January 2001): 39–56. http://dx.doi.org/10.5172/rsj.11.1.39.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hutchins, Brett. "‘The boy from bowral’: The role of the bush in the legend of Sir Donald Bradman." Journal of Australian Studies 29, no. 86 (January 2005): 29–35. http://dx.doi.org/10.1080/14443050509388029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Pascal, Jan. "A blessing not a curse: A mother-daughter guide to the transition from child to woman, Jane Bennett, Sally Milner Publishing, Bowral, NSW, 2006." Children Australia 31, no. 4 (2006): 36. http://dx.doi.org/10.1017/s1035077200011330.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Genel, F., N. Pavlovic, A. Lewin, R. Mittal, A. Huang, J. Penm, A. Patanwala, et al. "DOES OPIOID USE PRE-SURGERY PREDICT OUTCOMES TO SIX MONTHS FOLLOWING PRIMARY UNILATERAL KNEE OR HIP ARTHROPLASTY FOR OSTEOARTHRITIS? A RETROSPECTIVE STUDY." Orthopaedic Proceedings 105-B, SUPP_2 (February 2023): 74. http://dx.doi.org/10.1302/1358-992x.2023.2.074.

Full text

Abstract:

In the Unites States, approximately 24% of people undergoing primary total knee or total hip arthroplasty (TKA, THA) are chronic opioid users pre-operatively. Few studies have examined the incidence of opioid use prior to TKA/THA and whether it predicts outcomes post-surgery in the Australian context. The aim was to determine: (i) the proportion of TKA and THA patients who use opioids regularly (daily) pre-surgery; (ii) if opioid use pre-surgery predicts (a) complication and readmission rates to 6-months post-surgery, (b) patient-reported outcomes to 6-months post-surgery.A retrospective cohort study was undertaken utilising linked individual patient-level data from two independent databases comprising approximately 3500 people. Patients had surgery between January 2013 and June 2018, inclusive at Fairfield and Bowral Hospitals.Following data linkage, analysis was completed on 1185 study participants (64% female, 69% TKA, mean age 67 (9.9)). 30% were using regular opioids pre-operatively. Unadjusted analyses resulted in the following rates in those who were vs were not using opioids pre-operatively (respectively); acute adverse events (39.1% vs 38.6%), acute significant adverse events (5.3% vs 5.7%), late adverse events: (6.9% vs 6.6%), total significant adverse events: (12.5% vs 12.4%), discharge to inpatient rehab (86.4% vs 88.6%), length of hospital stay (5.9 (3.0) vs 5.6 (3.0) days), 6-month post-op Oxford Score (38.8 (8.9) vs 39.5 (7.9)), 6 months post-op EQ-VAS (71.7 (20.2) vs 76.7 (18.2), p<0.001), success post-op described as “much better” (80.2% vs 81.3%).Adjusted regression analyses controlling for multiple co-variates indicated no significant association between pre-op opioid use and adverse events/patient-reported outcomes.Pre-operative opioid use was high amongst this Australian arthroplasty cohort and was not associated with increased risk of adverse events post-operatively. Further research is needed in assessing the relationship between the amount of pre-op opioid use and the risk of post-operative adverse events.

APA, Harvard, Vancouver, ISO, and other styles

6

Olson, S. Douglas. "The 'Love Duet' In Aristophanes' Ecclesiazusae." Classical Quarterly 38, no. 2 (December 1988): 328–30. http://dx.doi.org/10.1017/s0009838800036995.

Full text

Abstract:

Over sixty years ago, Walter Headlam identified Ecclesiazusae 960–76 as a paraclausithyron, or song sung by an excluded lover from the street to his beloved within. In 1958, however, C. M. Bowra suggested that the whole of Eccl. 952–75 was actually the sole surviving example of a previously unrecognized genre of Greek lyric poetry, the informal love duet. The thesis has been widely accepted, and is adopted by Rossi, Henderson and Silk, as well as by the Oxford editor, Ussher, who rejects Headlam's identification explicitly. Only Zimmermann has failed to embrace Bowra's interpretation wholeheartedly, although he offers no detailed discussion of the passage. In fact, Eccl. 952–75 is not evidence for a lost lyric genre, but a sophisticated literary parody, carefully designed as an elaborate poetic comment on the larger action of the play in which it appears. Bowra's ‘love duet’ is a critical fantasy, whose fictional existence only serves to obscure the real purposes and humour of this Aristophanic love-song.

APA, Harvard, Vancouver, ISO, and other styles

7

Yablokova, E. A., S. A. Zyuzina, and E. V. Borisova. "Long-term Consequences Short Bowel Syndrome in a 13-year-old Child." Doctor.Ru 21, no. 7 (2022): 63–67. http://dx.doi.org/10.31550/1727-2378-2022-21-7-63-67.

Full text

Abstract:

Objective of the Paper: to demonstrate the observation of the long-term consequences of postresection short bowel syndrome in a 13-year- old boy. Key Рoints. Short bowel syndrome (SBS) is characterized by a low absorption capacity of the small intestine as a result of extensive resections, which is manifested by malabsorption, malnutrition and digestive disorders. Observation of a 13-year-old child with a history of postresection short bowel syndrome 10 years after acquiring intestinal autonomy (independence from parenteral nutrition) illustrates the long-term consequences SBS: megaloblastic B12-deficient anemia with neurological symptoms, delayed physical development, persistent anastomositis. Conclusion. In children with a history of short bowel syndrome, after acquiring intestinal autonomy, some risks remain that significantly disrupt the patient's health. Such patients need long-term food insurance and supervision by a multidisciplinary team of specialists. Keywords: short bowl syndrome, small intestine resection, malabsorption, parenteral nutrition, chronic intestinal failure, intestinal autonomy, B12-deficient anemia.

APA, Harvard, Vancouver, ISO, and other styles

8

Moya Sánchez, E., P. Pérez Naranjo, and V. Medina Salas. "Pseudoobstrucción de colon (síndrome de Ogilvie): un importante simulador de obstrucción colónica." Revista Andaluza de Patología Digestiva 43, no. 3 (June 30, 2020): 120–22. http://dx.doi.org/10.37352/2020433.3.

Full text

Abstract:

Resumen La pseudoobstrucción de colon puede diagnosticarse fácilmente y con precisión mediante tomografía computarizada (TC). Los hallazgos radiológicos consisten en una dilatación extensa del marco cólico sin evidencia de lesión obstructiva mecánica y una zona de transición de calibre intermedia localizada de forma típica en la flexura esplénica o adyacente a la misma. El tratamiento mediante descompresión colonoscópica mejora el pronóstico de los pacientes que presentan gran dilatación y mayor riesgo de isquemia y perforación.

APA, Harvard, Vancouver, ISO, and other styles

9

Othman, Nor Azizah. "An Analysis of the “A ” Entry in Thomas Bowrey’s Dictionary 1701." Jurnal Bahasa 19, no. 2 (December 2, 2019): 259–84. http://dx.doi.org/10.37052/jb.19(2)no4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Mutafchiyski, Ventsislav, Georgi Kotashev, Mihail Tabakov, Jasmina Mihailova, and Georgi Popivanov. "A CASE OF LAPAROSCOPIC-ASSISTED TREATMENT OF SMALL BOWEL INTUSSUSCEPTION DUE TO METASTASES FROM MALIGNANT MELANOMA - A WORD OF CAUTION." International Journal of Surgery and Medicine 2, no. 4 (2016): 230. http://dx.doi.org/10.5455/ijsm.laparoscopy-small-bowel-intussusception.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Bowral"

1

Trimingham, Jack Christine. "Kerever Park : a history of the experience of teachers and children in a Catholic girls' preparatory boarding school 1944-1965." Phd thesis, School of Social and Policy Studies in Education, 1997. http://hdl.handle.net/2123/6641.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Rees, Gail. "Diet, bowel function and irritable bowel syndrome." Thesis, London South Bank University, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.336373.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Noor, Nadim. "Small bowel motor responses in irritable bowel syndrome." Thesis, University of Newcastle Upon Tyne, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.311138.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Berrill, James. "Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease." Thesis, Cardiff University, 2014. http://orca.cf.ac.uk/61734/.

Full text

Abstract:

Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are both chronic relapsing intestinal disorders. Their symptom profiles overlap in terms of abdominal discomfort and altered bowel habit. Meta-‐analysis of patients with IBD demonstrates that 25-‐46% of those in clinical remission have symptoms compatible with IBS. These patients report lower quality of life scores compared to their asymptomatic counterparts. There is uncertainty as to the cause of these symptoms, and concern for the influence they may exert on clinical management. The work described in this thesis investigated the nature of IBS-‐type symptoms occurring in patients with IBD, examined potential diagnostic tools to distinguish between the respective conditions, and conducted a therapeutic trial for the management of functional symptoms in this setting. IBS-‐type symptoms were observed to occur more commonly in female IBD patients, were associated with high anxiety levels, and occurred in patients with no active inflammation as confirmed by a normal faecal calprotectin level. These findings are characteristic of irritable bowel syndrome, and suggest that this disorder may cause persistent symptoms during IBD remission. Two potential biomarkers of IBS were investigated. The first explored a hypothesis that IBS may be a systemic condition caused by the absorption of toxic metabolites produced by the bacterial fermentation of dietary carbohydrates. This mechanism would potentially explain both the gastrointestinal and the systemic symptoms that are observed in patients with IBS. It was proposed that toxic metabolites may covalently modify albumin in patients with IBS, however on investigation of this theory there was no significant difference observed between the plasma samples of IBS patients, IBD patients and healthy controls. The presence of systemic symptoms in patients with IBS and IBD was associated with higher anxiety levels. Cognitive function was also assessed as a potential biomarker of IBS following anecdotal reports that IBS patients experience impaired concentration. However no significant difference between IBS patients, IBD patients, and healthy controls was identified. Concurrent mood disorders, in particular depression, were associated with impaired performance of specific tasks in patients with IBD. A randomised-‐controlled trial of a mindfulness-‐based psychological intervention was performed in IBD patients with IBS-‐type symptoms or high perceived stress levels. Sub-‐group analysis demonstrated a significant improvement in quality of life in the intervention group in those patients who were experiencing IBS-‐type symptoms. Overall, these findings support the theory that IBS can cause persistent symptoms in IBD patients who are in remission. However, until the molecular mechanisms underlying IBS are identified and reliable biomarkers are developed, a systematic diagnostic approach is required to evaluate these patients. IBS-‐type symptoms in IBD patients represent a therapeutic target to improve quality of life and further trials of psychological intervention, medication and dietary modification are required.

APA, Harvard, Vancouver, ISO, and other styles

5

Cotterill, Lynn. "Inflammatory bowel disease genetics." Thesis, University of Manchester, 2011. https://www.research.manchester.ac.uk/portal/en/theses/inflammatory-bowel-disease-genetics(daae1a60-2790-4280-b7d5-ac5ec7533c7c).html.

Full text

Abstract:

Inflammatory bowel disease (IBD), which includes the subtypes Crohn's disease (CD) and ulcerative colitis (UC), is a common disease particularly in the Western world. IBD is characterised by inflammation of the small intestine and/or colon. The two subtypes affect different gut locations but both show an increased intestinal permeability or the 'leaky gut syndrome'. This led to the hypothesis that tight junction (TJ) proteins expressed in the epithelium may affect the intestinal permeability as a cause or effect of IBD.Initially, variants in the CARD15, IL23R and ATG16L1 genes, previously associated with an increased risk of IBD, were genotyped in a cohort of 500 IBD (295 CD and 205 UC) patients and 877 matched controls. These variants were significantly associated in our cohort. A random effects meta-analysis was undertaken on all previously reported CD associations with the variant rs2241880 from ATG16L1 (n=25, p=0.0017, OR: 1.36 95% CI 1.12-1.66) and with rs11209026 from IL23R (n=26, p=0.0006, OR: 0.37 95% CI 0.21-0.67), showing pooled odds ratios consistent with those reported in our cohort. Individuals carrying >1 CARD15 mutant variant were found to have a 2.5 fold increased risk of CD (p=0.0001). Candidate TJ proteins were chosen on the basis of previous reported associations and through the investigation of the claudin proteins which are abundant at TJs. Twenty one candidate genes were selected and 79 variants successfully genotyped in up to 1063 IBD (502 CD and 478 UC) and 870 control patients. Significant associations were detected with variants in the CLDN1, CLDN5 and CDH1 genes with CD; CLDN5, CLDN8 and CDH1 variants were associated to IBD; and the rs7791132 variant (between CLDN4 and ELN) and a CDH1 variant were associated to UC. The CLDN1 rs6809685 variant trended towards association in a Toronto ascertained IBD replication cohort (genotypic p=0.04, allelic p=0.06) suggesting this may be a novel IBD susceptibility variant. Small intestinal biopsies from CD patients with known rs6809685 genotypes showed a dose dependent reduced immunohistochemical staining of claudin 1 with carriage of the mutant G allele. Claudin 1 helps seal TJs and reduced levels may increase risk of CD.Peroxisome proliferator activator receptors (PPARs) can directly affect TJ proteins and could therefore affect intestinal permeability. Twelve PPARγ variants were genotyped in up to 1050 IBD (502 CD and 467 UC) and 725 control patients. Significant genotypic associations were found with the rs2067819 variant in CD (p=0.05) and IBD (p=0.02), and also the rs13099634 variant in UC (P=0.02). There was a strong gender difference particularly for rs2067819 and rs4135247, where allelic associations were highly significant and increased risk of IBD in men (p=0.01 and p=0.007 respectively). However no significant associations were found in the female cohort. Troglitazone a PPARα agonist increased Caco2 cell transepithelial electrical resistance (TEER), a marker of TJ integrity, and increased expression of claudins -3 and -4. In contrast, the PPARα antagonist GW6471 reduced the TEER without causing cell death and PPARγ ligands did not affect TEER measurements. In summary, using a robust cohort of cases and controls the data indicates that variants in genes encoding TJ proteins may affect susceptibility to IBD and that PPARs can regulate these proteins altering intestinal permeability.

APA, Harvard, Vancouver, ISO, and other styles

6

Gwee, Kok Ann. "Bowel disturbances following acute gastroenteritis : a psychobiophysiological model for the irritable bowel syndrome." Thesis, University of Sheffield, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.266724.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Cederholm, Myella. "INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME IN ADULT LIFE AFTER EXPERIENCING CHILDHOOD ABUSE." Thesis, Örebro universitet, Institutionen för medicinska vetenskaper, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-91412.

Full text

Abstract:

Introduction In a national survey from 2016, 5% of Swedish teenagers reported experience of repeated physical abuse and 6% reported repeated psychological abuse. Childhood abuse has been shown to enhance the risk of both psychiatric and somatic diseases, e.g. Irritable bowel syndrome (IBS) and also general inflammation. One type of inflammatory disease is inflammatory bowel disease (IBD), which is composed of Ulcerative colitis (UC) and Chron’s disease (CD), but there is limited scientific evidence regarding the correlation of IBD and child abuse. Objective The aim of this systematic review is to study the correlation between childhood abuse and IBD in adulthood and compare this to the correlation of child abuse and IBS. Method PubMed and Web of Science databases were searched for articles studying childhood maltreatment and adult IBS or IBD. Articles that were not peer reviewed and presented original data or did not study IBD patients were excluded. Results 342 articles were identified, of which nine met the pre-defined criteria and were included in this review. Eight articles studied the frequency of childhood abuse among IBS and IBD patients and one article studied disease activity in IBD patients that experienced childhood abuse. Childhood abuse was found to be more frequent in both IBS and IBD patients than healthy controls (HC). CD patients that were abused in childhood had elevated disease activity. Conclusions Childhood physical abuse was associated with both IBD and IBS. Childhood sexual abuse was associated with IBD, but a stronger association was found with IBS. No conclusions could be drawn regarding childhood psychological abuse.

APA, Harvard, Vancouver, ISO, and other styles

8

Harfmann-Ludwig, Susanne. "Bowel habits after bariatric surgery /." [S.l.] : [s.n.], 2009. http://www.ub.unibe.ch/content/bibliotheken_sammlungen/sondersammlungen/dissen_bestellformular/index_ger.html.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Pozuelo, del Río Marta. "Metagenomics in inflammatory bowel disease." Doctoral thesis, Universitat Autònoma de Barcelona, 2019. http://hdl.handle.net/10803/669437.

Full text

Abstract:

La microbiota intestinal desempeña un papel crucial en el manteniendo la homeostasis intesitnal. Alteraciones en la composición microbiana, también conocidas como disbisosis, pueden poner en peligro el estado de salud e incrementar el riesgo a padecer una enfermedad. Aunque muchas enfermedades se han asociado a cambios en la microbiota intestinal, todavía se desconoce si dichas alteraciones son la causa o la consecuencia de las patologías. La enfermedad inflamatoria intestinal (EII) es una enfermedad inflamatoria crónica que se caracteriza por periodos de inflamación y constituye un problema de salud dado. La EII presenta dos subtipos: enfermedad de Crohn y colitis ulcerosa, con síntomas similares pero diferentes manifestaciones clínicas. La EII se ha relacionado ampliamente con cambios en la microbiota intestinal. A pesar de los múltiples estudios que existen, no hay un claro consenso en el perfil microbiano asociado a la enfermedad. Las principales discordancias se dan entre las diferencias asociadas a enfermedad de Crohn y la colitis ulcerosa. Algunos investigadores han demostrado que la composición microbiana en colitis ulcerosa es muy similar a la de individuos sanos y ambas difieren de la composición de enfermos de Crohn. En cambio, otros investigadores han visto que las diferencias de colitis ulcerosa y Crohn respecto a sanos son muy similares por lo que consideran ambos subtipos como una única enfermedad (EII). El principal objetivo de esta tesis es determinar la disbiosis en una cohorte de EII española para evaluar hasta qué punto las funciones y composición microbiana difieren entre Crohn y colitis y si los datos de microbioma podrían emplearse como herramientas de diagnóstico. Para ello, analizamos muestras fecales de sanos, enfermos de Crohn y enfermos de colitis usando dos metodologías: secuenciación del gen 16SARNr (o 16S ADNr) y secuenciación por fragmentación del genoma. Como se preveía, observamos la presencia de disbiosis en EII. Además, vimos que las alteraciones en composición microbiana y funciones eran diferentes para Crohn que para colitis, mostrando una mayor disbiosis en Crohn que en enfermos de colitis ulcerosa y con colitis mostrando un patrón muy similar a la microbiota de individuos sanos. Los resultados funcionales encontrados en esta tesis confirman la mayor disbiosis descrita en pacientes de Crohn en comparación con pacientes de colitis ulcerosa en composición microbiana. Estos individuos presentan una mayor cantidad de genes principalmente asociados a metabolismo y enfermedades inmunes que los enfermos de colitis ulcerosa y sanos. A pesar de que los datos de 16S ADNr y secuenciación por fragmentación no detectaron las mismas diferencias entre Crohn y colitis, ambas metodologías permitieron la clasificación de los distintos subtipos de EII con una proporción similar. Más estudios son necesarios para validar los resultados de esta tesis en otras cohortes de pacientes que incluyan Crohn localizado en colon o pacientes recién diagnosticados que no hayan sido sometidos a tratamiento antes de la aplicación de estas metodologías como herramientas diagnósticas en clínica.
The gut commensal microbiota is known to play a crucial role in maintaining intestinal homeostasis. Alterations in the microbial community composition, also known as dysbiosis, may put health status in risk and increase susceptibility to diseases. Although several diseases have been related to shifts in the gut microbiome composition, it is still uncertain whether those alterations are the cause or consequence of the disease. Inflammatory bowel disease (IBD) is a chronic inflammatory disease with periods of active and inactive inflammation that constitutes to an important health problem. It is divided in two subtypes: Crohn’s disease (CD) and ulcerative colitis (UC) that present similar symptoms but different clinical manifestations. IBD has been widely associated with an alteration of the gut microbiome composition. Nevertheless, there is no clear consensus on the microbial pattern characteristic of the disorders. Main discordances between studies are related to differences between UC and CD. Some previous publications indicate that UC microbial composition is very similar to healthy and differs from CD whereas others consider both subtypes as a unique entity and find high alterations in UC and CD microbial composition in comparison with the microbiome of healthy individuals. The aim of this thesis was to characterize the dysbiosis in a Spanish IBD cohort to evaluate to which extend the gut microbiome composition and function could be differentiated between CD and UC and whether microbiome data could be used as diagnostic and prognostic tools. For this purpose, we analyzed fecal samples of healthy individuals, CD (affected in the ileum) and UC patients using two different methodologies: 16S rRNA gene (or 16S rDNA) and shotgun (short genomic fragments) sequencing. As expected, we observed the presence of dysbiosis in IBD. Furthermore, we showed that microbial composition and function alterations were different for CD and UC, with greater dysbiosis in CD than in UC and with UC resembling more to a healthy state. Functional findings also confirmed this higher dysbiosis in CD than in UC and revealed genes implicated in metabolism pathways and in immune diseases in higher abundance in CD compared with healthy individuals and UC. Although 16S rDNA and shotgun data did not detect differences in the dysbiosis in CD and UC in a consistent manner, both methodologies allowed the classification of IBD subtypes in a similar proportion. Future studies should validate these results using other patient cohorts such as colonic CD or recently diagnosed patients before the application of these techniques as diagnostic tools in clinical practice.

APA, Harvard, Vancouver, ISO, and other styles

10

Vandvik, Per Olav. "Irritable bowel syndrome in Norway." Doctoral thesis, Norwegian University of Science and Technology, Department of Cancer Research and Molecular Medicine, 2006. http://urn.kb.se/resolve?urn=urn:nbn:no:ntnu:diva-1698.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Bowral"

1

Dave, Thomas, ed. A vision splendid: A short history of Bradman Oval and the Bradman years in Bowral. Gungahlin, A.C.T: Willows House Publishing, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Bowman, W. C. Dictionary of pharmacology/cW.C. Bowman, Anne Bowman, Alison Bowman. Oxford: Blackwell Scientific, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Maurice Bowra: A life. Oxford: Oxford University Press, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

From yeomen to brickmasters: A biography of Frederick Baker, brickmaker 1842-1916 : and the history of his family from the end of the Middle Ages until 1940 : family brickyards at East Maitland, Bowral and Parkes and sometime Orange, Cowra and Swan Bay, New South Wales ... [New South Wales]: F. Baker, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bickish, David. Bush pilot bowman. Hamilton, MT: D. Bickish, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Dodd, Stella Maris. H.E. Bowman: Fotografías. [Buenos Aires, Argentina: Editorial Vinciguerra, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Barritt, Gordon E. Thomas Bowman Stephenson. Peterborough: Foundery Press, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Richard, Miller. Bowman Gray Stadium. Charleston, S.C: Arcadia Pub., 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bowman on Broadway. South Yarmouth, Ma: Curley, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Borwell, Barbara. Bowel Cancer. New York: John Wiley & Sons, Ltd., 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Bowral"

1

Martin, Susan K., Caroline Daley, Elizabeth Dimock, Cheryl Cassidy, and Cecily Devereux. "Missionary Exhibition at Bowral." In Women and Empire, 1750–1939, 205. London: Routledge, 2021. http://dx.doi.org/10.4324/9781003101857-46.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Khordipour, Errel, and Ee Tay. "Bowel." In Atlas of Handheld Ultrasound, 141–47. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-73855-0_27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kumar, Devinder. "Bowel." In Female Pelvic Reconstructive Surgery, 335–36. London: Springer London, 2003. http://dx.doi.org/10.1007/978-1-4471-0659-3_25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Collins, Brigitte, and Elissa Bradshaw. "The Background." In Bowel Dysfunction, 3–6. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43214-4_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Brundrett, Diane. "Food Choice as a Management Strategy in Bowel Dysfunction." In Bowel Dysfunction, 161–72. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43214-4_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kamperidis, Nikolaos, and Naila Arebi. "The Pharmacological Management of Chronic Constipation and Faecal Incontinence." In Bowel Dysfunction, 173–90. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43214-4_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Lyons, Monica. "Rectal Irrigation." In Bowel Dysfunction, 191–211. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43214-4_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Maeda, Yasuko, and Carolynne Vaizey. "Neuromodulation." In Bowel Dysfunction, 213–24. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43214-4_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Thomas, Gregory, and Carolynne Vaizey. "Surgery." In Bowel Dysfunction, 225–39. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43214-4_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Inspector, Yoram, and Avril Burns. "Psychological Medicine for Bowel Dysfunction." In Bowel Dysfunction, 241–62. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43214-4_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Bowral"

1

Bowman, Stan. "Stan Bowman." In the 29th International Conference. New York, New York, USA: ACM Press, 2002. http://dx.doi.org/10.1145/2931127.2931140.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

"Author index." In 2022 Proceedings of the Bowman Club Meeting, 25th March. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/bmjophth-2022-bcm.authorindex.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ahmad, Nadeem, Ruby Lagnado, and Chung Bong. "P-12 A case of Descemet’s membrane detachment following penetrating keratoplasty for keratoconus." In 2022 Proceedings of the Bowman Club Meeting, 25th March. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/bmjophth-2022-bcm.9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

García-Onrubia, Luis, Nick Stanojcic, and Maninder Bhogal. "P-15 Utilising endothelial migration to perform deep anterior lamellar keratoplasty in eyes with deep posterior corneal scarring typically treated with penetrating keratoplasty." In 2022 Proceedings of the Bowman Club Meeting, 25th March. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/bmjophth-2022-bcm.12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bizrah, Mukhtar, Po Hsiang Yuan, Geoffrey Ching, and Simon P. Holland. "P-13 Trans-epithelial phototherapeutic keratectomy (PTK) for recurrent corneal erosion syndrome (RCES)." In 2022 Proceedings of the Bowman Club Meeting, 25th March. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/bmjophth-2022-bcm.10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

García-Onrubia, Luis, Nick Stanojcic, Jing Hua, and Maninder Bhogal. "OP-4 Descemet membrane endothelial keratoplasty patching (DMEP) – selective endothelial replacement in eyes with localised endothelial dysfunction." In 2022 Proceedings of the Bowman Club Meeting, 25th March. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/bmjophth-2022-bcm.4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Fu, Lana, and Emma J. Hollick. "P-14 Descemet stripping endothelial keratoplasty versus Descemet membrane endothelial keratoplasty: 5-year graft survival and endothelial cell loss in patients with Fuchs’ endothelial dystrophy." In 2022 Proceedings of the Bowman Club Meeting, 25th March. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/bmjophth-2022-bcm.11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kaye, Stephen, Keri McLean, Daniel M. Foulkes, Marta Sloniecka, Dominic Byrne, Atikah S. Haneef, Craig Winstanley, Neil G. Berry, and David G. Fernig. "P-18 Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicity." In 2022 Proceedings of the Bowman Club Meeting, 25th March. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/bmjophth-2022-bcm.15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Mukherjee, Hatch, Spyros Pipis, and Yunfei Yang. "OP-5 Femtosecond enabled keratoplasty techniques for keratoplasty." In 2022 Proceedings of the Bowman Club Meeting, 25th March. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/bmjophth-2022-bcm.5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Yusuf, Mustafa, Chung Bong, and Akash Dharni. "P-20 Galilei topography vs Anterion topography. Same patient, different results?" In 2022 Proceedings of the Bowman Club Meeting, 25th March. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/bmjophth-2022-bcm.17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Bowral"

1

Dai, Ning, Qingyun He, Qiao Wen, Yifei Zhang, Shibing Liang, Jiali Wei, Jingli Xing, and Jianping Liu. Placebo effect in patients with diarrhea-type irritable bowel syndrome: a literature review of randomized, placebo-controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2022. http://dx.doi.org/10.37766/inplasy2022.6.0019.

Full text

Abstract:

Review question / Objective: The aim of this systematic review is to explore the magnitude of the placebo effect in randomized controlled trials for diarrhea-type irritable bowel syndrome and to understand possible relevant factors that affect the placebo effect. Condition being studied: Irritable bowel syndrome is a chronic functional gastrointestinal disorder characterized by abdominal pain related to defecation and a change in frequency and form of stool. Epidemiological study indicates that the prevalence of irritable bowel syndrome in different countries is high. It is estimated conservatively that direct costs related to irritable bowel syndrome causes a huge economic burden in the United States. In the latest Rome IV criteria, irritable bowel syndrome is divided into 4 subtypes based on abnormal bowel habits: irritable bowel syndrome with predominant constipation, irritable bowel syndrome with predominant diarrhea, irritable bowel syndrome with mixed bowel habits, and irritable bowel syndrome unclassified. Regarding treatment for irritable bowel syndrome, there is no cure or curative treatment. Any agent should be compared with placebo to identify its efficacy. In fact, the placebo response rate of irritable bowel syndrome is high. However, the placebo response rate of IBS-D and the moderators of the magnitude of the placebo response rate are not clear.

APA, Harvard, Vancouver, ISO, and other styles

2

Dai, Ning, Qingyun He, Qiao Wen, Yifei Zhang, Shibing Liang, Jiali Wei, Jingli Xing, and Jianping Liu. Placebo effect in patients with diarrhea-type irritable bowel syndrome: a literature review of randomized, placebo-controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2022. http://dx.doi.org/10.37766/inplasy2022.6.0019.

Full text

Abstract:

Review question / Objective: The aim of this systematic review is to explore the magnitude of the placebo effect in randomized controlled trials for diarrhea-type irritable bowel syndrome and to understand possible relevant factors that affect the placebo effect. Condition being studied: Irritable bowel syndrome is a chronic functional gastrointestinal disorder characterized by abdominal pain related to defecation and a change in frequency and form of stool. Epidemiological study indicates that the prevalence of irritable bowel syndrome in different countries is high. It is estimated conservatively that direct costs related to irritable bowel syndrome causes a huge economic burden in the United States. In the latest Rome IV criteria, irritable bowel syndrome is divided into 4 subtypes based on abnormal bowel habits: irritable bowel syndrome with predominant constipation, irritable bowel syndrome with predominant diarrhea, irritable bowel syndrome with mixed bowel habits, and irritable bowel syndrome unclassified. Regarding treatment for irritable bowel syndrome, there is no cure or curative treatment. Any agent should be compared with placebo to identify its efficacy. In fact, the placebo response rate of irritable bowel syndrome is high. However, the placebo response rate of IBS-D and the moderators of the magnitude of the placebo response rate are not clear.

APA, Harvard, Vancouver, ISO, and other styles

3

Dong, Tiantian, Yuanxiang Liu, and Jiguo Yang. A network meta-analysis of Moxibustion for Diarrhoea-Predominant Irritable Bowel SyndromeMoxibustion for Diarrhoea-Predominant Irritable Bowel Syndrome. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2021. http://dx.doi.org/10.37766/inplasy2021.8.0003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Gu, Baijian, Jianhua Zhou, Zhe Yu, Chong Shi, and Bixin Chen. Effects of Low-FODMAP diet on irritable bowel symptoms in patients with quiescent inflammatory bowel disease：A SystematicReview and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2022. http://dx.doi.org/10.37766/inplasy2022.1.0081.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Hornbeck, Richard. Dust Bowl Migrants: Identifying an Archetype. Cambridge, MA: National Bureau of Economic Research, August 2020. http://dx.doi.org/10.3386/w27656.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Olsen, A. S., and C. T. Wake. Inflammatory Bowel Disease Gene Discovery Final Report CRADA No. TC-1335-96. Office of Scientific and Technical Information (OSTI), March 2018. http://dx.doi.org/10.2172/1430922.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Yao, Chengjiao, Yilin Li, Mengjun Pu, Fengjiao Xie, Qin Xiong, Lihong Luo, and Peiming Feng. Traditional chinese medicine for irritable bowel syndrome: a protocol for meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2020. http://dx.doi.org/10.37766/inplasy2020.10.0052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Tate, Denise G. Psychosocial and Behavioral Factors Associated with Bowel and Bladder Management after SCI. Fort Belvoir, VA: Defense Technical Information Center, October 2013. http://dx.doi.org/10.21236/ada597623.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Tate, Denise G. Psychosocial and Behavioral Factors Associated with Bowel and Bladder Management after SCI. Fort Belvoir, VA: Defense Technical Information Center, October 2015. http://dx.doi.org/10.21236/ada626293.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tate, Denise G. Psychosocial and Behavioral Factors Associated with Bowel and Bladder Management after SCI. Fort Belvoir, VA: Defense Technical Information Center, October 2014. http://dx.doi.org/10.21236/ada626310.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!